Tuberculoid leprosy

Tuberculoid leprosy is a form of leprosy characterized by a strong immune response to the bacterium Mycobacterium leprae. It is one of the two major forms of leprosy, the other being lepromatous leprosy. Tuberculoid leprosy is considered to be a less severe form of the disease.
Clinical features
Tuberculoid leprosy presents with a limited number of skin lesions, which are often dry, hairless, and hypopigmented. These lesions are typically anesthetic due to the involvement of peripheral nerves. The immune response in tuberculoid leprosy is characterized by a strong cell-mediated immunity, which helps to contain the infection but also leads to nerve damage.
Pathophysiology
The pathophysiology of tuberculoid leprosy involves a robust Th1 immune response, which is effective in controlling the proliferation of Mycobacterium leprae. This immune response results in the formation of granulomas in the skin and nerves, which are collections of immune cells that attempt to wall off the bacteria.
Diagnosis
Diagnosis of tuberculoid leprosy is based on clinical examination, skin smears, and skin biopsy. The skin lesions in tuberculoid leprosy are often paucibacillary, meaning they contain few bacteria, which can make diagnosis challenging. Histopathological examination of a biopsy can reveal the presence of granulomas and nerve involvement.
Treatment
The treatment of tuberculoid leprosy involves multidrug therapy (MDT) as recommended by the World Health Organization (WHO). The standard regimen includes dapsone and rifampicin for a period of six months. Early diagnosis and treatment are crucial to prevent nerve damage and disability.
Prognosis
The prognosis for individuals with tuberculoid leprosy is generally good, especially with early diagnosis and appropriate treatment. The strong immune response helps to limit the spread of the bacteria, and most patients respond well to therapy. However, nerve damage can be permanent if not treated promptly.
Related pages
Ad. Transform your life with W8MD's
GLP-1 weight loss injections special from $29.99


W8MD Medical Weight Loss, Sleep and Medspa offers physician-supervised medical weight loss programs: NYC medical weight loss Philadelphia medical weight loss
Affordable GLP-1 Weight Loss ShotsAffordable GLP-1 Weight Loss Shots
Budget GLP-1 injections NYC (insurance & self-pay options) Popular treatments:
- Semaglutide starting from $29.99/week
- Tirzepatide starting from $45.00/week
✔ Most insurances accepted for visits ✔ Prior authorization support when eligible
Start your physician weight loss NYC journey today:
📍 NYC: Brooklyn weight loss center 📍 Philadelphia: Philadelphia weight loss center
📞 Call: 718-946-5500 (NYC) | 215-676-2334 (Philadelphia)
Tags: Affordable GLP1 weight loss NYC, Wegovy NYC, Zepbound NYC, Philadelphia medical weight loss
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian